Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
1.
Eur Rev Med Pharmacol Sci ; 25(20): 6356-6364, 2021 Oct.
Article de Anglais | MEDLINE | ID: mdl-34730217

RÉSUMÉ

OBJECTIVE: This study evaluated single intra-articular injections of Hymovis MO.RE., a hyaluronic acid hexadecyl derivative (HYADD4-G), to manage post-traumatic or degenerative knee or ankle chondropathy in professional soccer players. PATIENTS AND METHODS: Twenty-five players affected by knee (n = 12) or ankle (n = 13) chondropathy were prospectively enrolled and treated by two single Hymovis MO.RE. (32 mg/4 ml) injections at the beginning of the football season (V0, baseline) and at mid-season (V1, 19-20 weeks thereafter), and were followed-up until the end of the season (V2, after further 19-20 weeks). Knee cases were evaluated using the 2000 IKDC knee subjective examination form and the modified Lysholm scoring system. Ankle cases were evaluated using the American Orthopaedic Foot Ankle Society (AOFAS) ankle-hindfoot score. Patients were also evaluated using a VAS Likert scale and a four-category scale recording both the patient's and the doctor's assessment on joint mobility in degrees and overall treatment efficacy. Adverse events, patient withdrawals and local reaction to injections were also assessed. RESULTS: In knee patients, the 2000 IKDC subjective score improved from 46.8 ± 11.4 at V0 to 83.1 ± 12.5 at V2. Their modified Lysholm score improved from 58.8 ± 8.9 at V0 to 90.6 ± 8.3 at V2. In the ankle patients, the AOFAS score improved from 52.2 ± 5.6 at V0 to 96.4 ± 4.5 at V2. VAS Likert values and subjective evaluations improved at V1 and were maintained at V2. No side effects were recorded. CONCLUSIONS: A single Hymovis MO.RE. (32 mg/4 ml) intra-articular injection, repeated after 19-20 weeks, may be a viable option to improve symptoms and function in professional soccer players suffering from knee and ankle chondropathy.


Sujet(s)
Articulation talocrurale/effets des médicaments et des substances chimiques , Maladies du cartilage/traitement médicamenteux , Acide hyaluronique/administration et posologie , Articulation du genou/effets des médicaments et des substances chimiques , Articulation talocrurale/physiopathologie , Athlètes , Maladies du cartilage/physiopathologie , Études de cohortes , Études de suivi , Humains , Acide hyaluronique/effets indésirables , Injections articulaires , Articulation du genou/physiopathologie , Études prospectives , Amplitude articulaire , Football , Résultat thérapeutique
2.
J Colloid Interface Sci ; 250(1): 251-60, 2002 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-16290658

RÉSUMÉ

Sizing glass fibers with silane coupling agents enhances the adhesion and the durability of the fiber/polymer matrix interface in composite materials. There are several tests to determine the interfacial strength between a fiber and resin, but all of them present difficulties in interpreting the results and/or sample preparation. In this study, we observed the influence of different aminosilanes fiber coatings on the resistance of epoxy-based composite materials using a very easy fractographic test. In addition, we tried a new fluorescence method to get information on a molecular level precisely at the interface. Strength was taken into account from two standpoints: (i) mechanical strength and (ii) the resistance to hydrolysis of the interface in oriented glass-reinforced epoxy-based composites. Three silanes: gamma-aminopropyltriethoxysilane, gamma-Aminopropylmethyldiethoxysilane, and gamma-Aminopropyldimethylethoxysilane were used to obtain different molecular structures at the interface. It was concluded that: (i) the more accessible amine groups are, the higher the interface rigidity is; (ii) an interpenetrating network mechanism seems to be the most important for adhesion and therefore to the interfacial strength; and (iii) the higher the degree of crosslinking in the silane coupling layer is, the higher the hydrolytic damage rate is.

3.
Am J Vet Res ; 53(3): 364-7, 1992 Mar.
Article de Anglais | MEDLINE | ID: mdl-1317689

RÉSUMÉ

Pigs (9 [+/- 1] weeks old) were inoculated with Streptococcus suis type 2, pseudorabies virus (PRV), or both. For each pig of groups A, B, and C the inoculum of S suis was 10(9) colony-forming units. For each pig of groups A, B, and D the inoculum of PRV was 5 x 10(3) TCID50 of either PRV strain 4892 (group A, n = 9) or PRV isolate B (group B, n = 9). The PRV strain 4892 is a highly virulent strain; isolate B causes mild clinical signs of infection in inoculated pigs. Group-C pigs (n = 9) were given S suis alone, and group-D pigs (n = 3) were inoculated only with PRV isolate B. Clinical signs of infection and development of lesions were readily seen in pigs of groups A, B, and C. Duration and severity of clinical signs of disease and lesions were reduced in pigs of group C, compared with those of the other 2 groups. Lesions, such as polyarthritis and fibrinous pericarditis, were more abundant and acute in the groups of pigs given mixed challenge exposure, compared with pigs inoculated exclusively with S suis type 2 (group C). The group of pigs inoculated with PRV isolate B alone did not manifest clinical signs of disease or lesions. Average daily gain for group-C pigs was higher, compared with that of other groups; the difference was statistically significant at P less than 0.02 and P less than 0.05 for groups B and D, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)


Sujet(s)
Herpèsvirus porcin de type 1/physiologie , Maladie d'Aujeszky/complications , Infections à streptocoques/médecine vétérinaire , Streptococcus suis/physiologie , Maladies des porcs/microbiologie , Animaux , Profilage d'ADN , ADN bactérien/analyse , Herpèsvirus porcin de type 1/pathogénicité , Maladie d'Aujeszky/microbiologie , Maladie d'Aujeszky/anatomopathologie , Infections à streptocoques/complications , Infections à streptocoques/microbiologie , Infections à streptocoques/anatomopathologie , Streptococcus suis/génétique , Suidae , Maladies des porcs/anatomopathologie , Virulence
4.
Vet Microbiol ; 16(3): 243-54, 1988 Mar.
Article de Anglais | MEDLINE | ID: mdl-2836996

RÉSUMÉ

The effect of Aujeszky's disease virus (ADV) infection in the last third of gestation was studied using two clones from an ADV isolate. Twelve sows were infected with one or other clone at 85 +/- 1 days of gestation. The dose of infection was 5 X 10(6) TCID50 per sow. The clinical and serological responses to the infection were different. One clone, Ls-1, produces a severe and acute illness. The course of the disease went from 9 to 14 days while the other clone, Ls-2, caused a mild or silent infection and for a shorter time. Transplacental infection occurred in only one sow which had been infected with Ls-2. The litter consisted of 8 mummified fetuses. Sows infected with Ls-1 produced piglets or mummified fetuses that were virus-negative. Perinatal infection was found in litters from both groups. Colostrum-deprived piglets that did not have postpartum contact with the sow, produced specific antibodies, 2 out of 6 born to sows infected with Ls-1 and 1 out of 4 born to sows infected with Ls-2. The antibody titers in colostrum-fed piglets were related to the extent of clinical response of the sows to the infection. Litters born to sows infected with Ls-1 had mean SNT titers from 1/12 to 1/112 while litters born to sows infected with Ls-2 showed titers of 1/2 or less than 2.


Sujet(s)
Maladies foetales/médecine vétérinaire , Complications infectieuses de la grossesse/médecine vétérinaire , Maladie d'Aujeszky/transmission , Maladies des porcs/transmission , Animaux , Anticorps antiviraux/biosynthèse , Antigènes viraux/analyse , Poids de naissance , Clones cellulaires , Test ELISA , Femelle , Maladies foetales/étiologie , Technique d'immunofluorescence , Herpèsvirus porcin de type 1/immunologie , Herpèsvirus porcin de type 1/isolement et purification , Échange foetomaternel , Tests de neutralisation , Placenta , Grossesse , Complications infectieuses de la grossesse/immunologie , Maladie d'Aujeszky/immunologie , Suidae , Maladies des porcs/immunologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE